Amgen Inc (NASDAQ:AMGN)

177.47
Delayed Data
As of Apr 18
 -5.00 / -2.74%
Today’s Change
165.22
Today|||52-Week Range
210.19
-8.84%
Year-to-Date

Today’s Trading

Previous close182.47
Today’s open183.24
Day’s range176.85 - 183.49
Volume8,266,592
Average volume (3 months)3,073,674
Market cap$117.9B
Data as of 4:00pm ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)+368.59%
Earnings growth (this year)-1.80%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+4.32%
P/E ratio14.1
Price/Sales5.45
Price/Book9.64

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.30-0.47%
ILMNIllumina Inc+0.34+0.11%
BIIBBiogen-0.79-0.35%
EXASExact Sciences Corp+0.40+0.44%
Data as of 4:00pm ET, 04/18/2019

Financials

Next reporting dateMay 1, 2019
EPS forecast (this quarter)$3.51
Annual revenue (last year)$23.8B
Annual profit (last year)$8.4B
Net profit margin35.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts